Our previous evidence demonstrated that TSN could induce lipid metabolism disorder by inhibiting the liver X receptor α (LXRα)/lipin 1/sterol regulatory element-binding protein 1 (SREBP1) signaling pathway, contributing to HILI [11]. The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.